Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease
Journal of Controlled Release · 2023-11 · 363 · 149-179
DOI: 10.1016/j.jconrel.2023.09.033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2023-11. Verfasst von Wanyue Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, PR China; Anhui Engin…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Nanostructures. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 262 Literaturangaben.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disorder that affects the entire gastrointestinal tract and is associated with an increased risk of colorectal cancer. Mainstream clinical testing methods are time-consuming, painful for patients, and insufficiently sensitive to detect early symptoms. Currently, there is no definitive cure for IBD, and frequent doses of medications with potentially severe side effects may affect patient response. In recent years, nanomaterials have demonstrated considerable potential for IBD management due to their diverse structures, composition, and physical and chemical properties. In this review, we provide an overview of the advances in nanomaterial-based diagnosis and treatment of IBD in recent five years. Multi-functional bio-nano platforms, including contrast agents, near-infrared (NIR) fluorescent probes, and bioactive substance detection agents have been developed for IBD diagnosis. Based on a series of pathogenic characteristics of IBD, the therapeutic strategies of antioxidant, anti-inflammatory, and intestinal microbiome regulation of IBD based on nanomaterials are systematically introduced. Finally, the future challenges and prospects in this field are presented to facilitate the development of diagnosis and treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, Hefei 230032, PR China; Anhui Engineering Research Center for Medical Micro-Nano Devices, Hefei, Anhui 23…
- School of Stomatology, Anhui Medical University, Hefei, Anhui 230032, PR China.
Zitieren
APA
Fu, W., Xu, L., Chen, Z., Kan, L., Ma, Y., Qian, H., & Wang, W. (2023). Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease. Journal of Controlled Release, 363, 149-179. https://doi.org/10.1016/j.jconrel.2023.09.033
Vancouver
Fu W, Xu L, Chen Z, Kan L, Ma Y, Qian H, et al. Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease. Journal of Controlled Release. 2023;363:149-179. doi:10.1016/j.jconrel.2023.09.033
BibTeX
@article{Fu2023,
author = {Fu, Wanyue and Xu, Lingling and Chen, Zetong and Kan, Lingling and Ma, Yan and Qian, Haisheng and Wang, Wanni},
title = {Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease},
journal = {Journal of Controlled Release},
year = {2023},
volume = {363},
pages = {149--179},
doi = {10.1016/j.jconrel.2023.09.033}
}
EUVIMED